D
Do Young Kim
Researcher at Yonsei University
Publications - 737
Citations - 18320
Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Op0146 efficacy of apremilast for oral ulcers associated with active behçet’s syndrome over 64 weeks: results from a phase iii study
Gulen Hatemi,Alfred Mahr,Mitsuhiro Takeno,Do Young Kim,David Saadoun,Haner Direskeneli,Sue Cheng,Shannon McCue,Maria Paris,Mindy Chen,Yusuf Yazici +10 more
TL;DR: APR demonstrated efficacy and safety for the treatment of OU associated with Behçet’s syndrome in the phase III RELIEF study for up to 64 wks and at 4-wk follow-up (after APR discontinuation), with significantly greater improvements with APR observed in complete and partial response of OU at Wk 12.
Journal ArticleDOI
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.
Jeong-Ju Yoo,Yang Jae Yoo,Woo Ram Moon,Seung Up Kim,Soung Won Jeong,Ha Na Park,Min Gyu Park,Jae Young Jang,Su Yeon Park,Beom Kyung Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Kwang Hyub Han,Sang Gyune Kim,Young Seok Kim,Ji Hoon Kim,Jong Eun Yeon,Kwan Soo Byun +18 more
TL;DR: The correlation of the degree of HS between CAP and US was significantly high in patients with HS, and the optimal cut-off CAP values for grade 2 to 3 and grade 3 HS were 284.5 and 298.5 dB/m.
Journal ArticleDOI
Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress
Jin-Ok Baek,Dashlkhumbe Byamba,Tae-Gyun Kim,Dae Suk Kim,Do Young Kim,Soo Min Kim,Min Geol Lee +6 more
Journal ArticleDOI
Child Onset Cutaneous Cymphodenia
TL;DR: Letters to the Editor are welcomed for publication (subject to editing).
Journal ArticleDOI
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
Sang Hyun Seo,Da Hyun Lee,Yu Seol Lee,Kyung Joo Cho,Hye Jung Park,Hye Won Lee,Beom Kyung Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Soo Han Bae,Seung U. Kim +11 more
TL;DR: Combination therapy involving UDCA and RSV/EZE may be a novel strategy for potent inhibition of NAFLD progression.